Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07139860

Artificial Intelligence System for Early Warning of Adverse Events in Acute Myocardial Infarction

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,400 (estimated)
Sponsor
Hui Chen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The goal of this observational study is to learn about the effectiveness of an artificial intelligence-based early warning system for predicting adverse events in patients with acute myocardial infarction (AMI). The main question it aims to answer is: Does an AI-based early warning system improve the assessment and prediction of adverse events across the full course of AMI care (from prevention to diagnosis, treatment, and rehabilitation)? Participants who are receiving routine medical care for AMI in tertiary hospitals will have their multimodal medical data (clinical records, diagnostic tests, imaging, treatment pathways) collected and analyzed. Data will be integrated using innovative cross-modal representation methods and predictive models. The study will follow patients during their hospital stay and subsequent clinical follow-up to evaluate the feasibility, accuracy, and clinical value of the AI-based early warning system.

Conditions

Timeline

Start date
2022-11-26
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-08-24
Last updated
2025-08-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07139860. Inclusion in this directory is not an endorsement.